Travere Therapeutics TVTX reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Travere Therapeutics beat estimated earnings by 29.91%, reporting an EPS of $-0.82 versus an estimate of $-1.17.
Revenue was up $8.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.31 which was followed by a 1.92% increase in the share price the next day.
Here's a look at Travere Therapeutics's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -1.07 | -0.89 | -0.88 | -0.85 |
EPS Actual | -0.76 | -0.76 | -0.65 | -0.82 |
Revenue Estimate | 53.01M | 54.76M | 49.63M | 51.92M |
Revenue Actual | 55.87M | 53.50M | 54.17M | 48.49M |
To track all earnings releases for Travere Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.